Infiltration of peritumoural but tumour-free parenchyma with IgG4-positive plasma cells in hilar cholangiocarcinoma and pancreatic adenocarcinoma

Digestive and Liver Disease

Volumn 45, Issue 10, 2013, Pages 859-865

  Resheq, Yazid J ^a   Quaas, Alexander ^a   von Renteln, Daniel ^a   Schramm, Christoph ^a   Lohse, Ansgar W ^a   Lüth, Stefan ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Autoimmune pancreatitis; IgG4; IgG4 associated cholangitis; Malignancy

Indexed keywords

ALANINE AMINOTRANSFERASE; BILIRUBIN; IMMUNOGLOBULIN G4;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BILE DUCT CARCINOMA; BILIRUBIN BLOOD LEVEL; CANCER SURGERY; CHOLANGITIS; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; LYMPHOCYTIC INFILTRATION; MALE; PANCREAS ADENOCARCINOMA; PLASMA CELL; PRIORITY JOURNAL; TUMOR IMMUNOLOGY;

AUTOIMMUNE PANCREATITIS; IGG4; IGG4-ASSOCIATED CHOLANGITIS; MALIGNANCY;

ADENOCARCINOMA; AGED; ALANINE TRANSAMINASE; AUTOIMMUNE DISEASES; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; BILIRUBIN; CHOLANGIOCARCINOMA; CHOLANGITIS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; PANCREAS; PANCREATIC NEOPLASMS; PANCREATITIS; PLASMA CELLS;

EID: 84883751217     PISSN: 15908658     EISSN: 18783562     Source Type: Journal    
DOI: 10.1016/j.dld.2013.03.007     Document Type: Article

References (38)

1. Ghazale A., Chari S.T., Zhang L., et al. Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy. Gastroenterology 2008, 134:706-715.
2. Alderlieste Y.A., van den Elzen B.D., Rauws E.A., et al. Immunoglobulin G4-associated cholangitis: one variant of immunoglobulin G4-related systemic disease. Digestion 2009, 79:220-228.
3. Hamano H., Kawa S., Uehara T., et al. Immunoglobulin G4-related lymphoplasmacytic sclerosing cholangitis that mimics infiltrating hilar cholangiocarcinoma: part of a spectrum of autoimmune pancreatitis?. Gastrointestinal Endoscopy 2005, 62:152-157.
4. Miglani R.K., Murthy D., Bhat R., et al. Immunoglobulin G4-associated cholangitis mimicking cholangiocarcinoma in a young boy. Journal of Postgraduate Medicine 2010, 56:140-142.
5. Ohara H., Okazaki K., Tsubouchi H., et al. Clinical diagnostic criteria of IgG4-related sclerosing cholangitis 2012. Journal of Hepato-Biliary-Pancreatic Science 2012, 9:536-542.
6. Chari S.T., Smyrk T.C., Levy M.J., et al. Diagnosis of autoimmune pancreatitis: the Mayo Clinic experience. Clinical Gastroenterology and Hepatology 2006, 4:1010-1016.
7. Stone J.H., Zen Y., Deshpande V. IgG4-related disease. New England Journal of Medicine 2012, 366:539-551.
8. Smyrk T.C. Pathological features of IgG4-related sclerosing disease. Current Opinion in Rheumatology 2011, 23:74-79.
9. Tanabe T., Tsushima K., Yasuo M., et al. IgG4-associated multifocal systemic fibrosis complicating sclerosing sialadenitis, hypophysitis, and retroperitoneal fibrosis, but lacking pancreatic involvement. Internal Medicine 2006, 45:1243-1247.
10. Raina A., Yadav D., Krasinskas A.M., et al. Evaluation and management of autoimmune pancreatitis: experience at a large US center. American Journal of Gastroenterology 2009, 104:2295-2306.
11. Takikawa H., Takamori Y., Tanaka A., et al. Analysis of 388 cases of primary sclerosing cholangitis in Japan; presence of a subgroup without pancreatic involvement in older patients. Hepatology Research 2004, 29:153-159.
12. Church N.I., Pereira S.P., Deheragoda M.G., et al. Autoimmune pancreatitis: clinical and radiological features and objective response to steroid therapy in a UK Series. American Journal of Gastroenterology 2007, 102:2417-2425.
13. Hirano K., Tada M., Isayama H., et al. Long-term prognosis of autoimmune pancreatitis with and without corticosteroid treatment. Gut 2007, 56:1719-1724.
14. Takuma K., Kamisawa T., Tabata T., et al. Short-term and long-term outcomes of autoimmune pancreatitis. European Journal of Gastroenterology and Hepatology 2011, 23:146-152.
15. Naitoh I., Nakazawa T., Ohara H., et al. Endoscopic transpapillary intraductal ultrasonography and biopsy in the diagnosis of IgG4-related sclerosing cholangitis. Journal of Gastroenterology 2009, 44:1147-1155.
16. Kamisawa T., Egawa N., Nakajima H., et al. Clinical difficulties in the differentiation of autoimmune pancreatitis and pancreatic carcinoma. American Journal of Gastroenterology 2003, 98:2694-2699.
17. Padilla D., Cubo T., Villarejo P., et al. Response to steroid therapy of sclerosing cholangitis after duodenopancreatectomy due to autoimmune pancreatitis. Gut 2005, 549:1348-1349.
18. Shimosegawa T., Chari S.T., Frulloni L., et al. International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology. Pancreas 2011, 40:352-358.
19. Deshpande V., Zen Y., Chan J.K., et al. Consensus statement on the pathology of IgG4-related disease. Modern Pathology 2012, 25:1181-1192.
20. Dhall D., Suriawinata A.A., Tang L.H., et al. Use of immunohistochemistry for IgG4 in the distinction of autoimmune pancreatitis from peritumoral pancreatitis. Human Pathology 2010, 41:643-652.
21. Lytras D., Kalaitzakis E., Webster G.J., et al. Cholangiocarcinoma or IgG4-associated cholangitis: how feasible it is to avoid unnecessary surgical interventions?. Annals of Surgery 2012, 256:1059-1067.
22. Zen Y., Quaglia A., Portmann B. Immunoglobulin G4-positive plasma cell infiltration in explanted livers for primary sclerosing cholangitis. Histopathology 2011, 58:414-422.
23. Ghazale A., Chari S.T., Smyrk T.C., et al. Value of serum IgG4 in the diagnosis of autoimmune pancreatitis and in distinguishing it from pancreatic cancer. American Journal of Gastroenterology 2007, 102:1646-1653.
24. Buc E., Lesurtel M., Belghiti J. Is preoperative histological diagnosis necessary before referral to major surgery for cholangiocarcinoma?. HPB (Oxford) 2008, 10:98-105.
25. Kloek J.J., van Delden O.M., Erdogan D., et al. Differentiation of malignant and benign proximal bile duct strictures: the diagnostic dilemma. World Journal of Gastroenterology 2008, 14:5032-5038.
26. Jailwala J., Fogel E.L., Sherman S., et al. Triple-tissue sampling at ERCP in malignant biliary obstruction. Gastrointestinal Endoscopy 2000, 51:383-390.
27. Wiersema M.J., Hawes R.H., Tao L.C., et al. Endoscopic ultrasonography as an adjunct to fine needle aspiration cytology of the upper and lower gastrointestinal tract. Gastrointestinal Endoscopy 1992, 38:35-39.
28. Sepehr A., Mino-Kenudson M., Ogawa F., et al. IgG4+ to IgG+ plasma cells ratio of ampulla can help differentiate autoimmune pancreatitis from other "mass forming" pancreatic lesions. American Journal of Surgical Pathology 2008, 32:1770-1779.
29. Taylor B. Carcinoma of the head of the pancreas versus chronic pancreatitis: diagnostic dilemma with significant consequences. World Journal of Surgery 2003, 27:1249-1257.
30. Fogel E.L., DeBellis M., McHenry L., et al. Effectiveness of a new long cytology brush in the evaluation of malignant biliary obstruction: a prospective study. Gastrointestinal Endoscopy 2006, 63:71-77.
31. Culver E.L., Bateman A.C. IgG4-related disease: can non-classical histopathological features or the examination of clinically uninvolved tissues be helpful in the diagnosis?. Journal of Clinical Pathology 2012, 65:963-969.
32. Zhang L., Chari S., Smyrk T.C., et al. Autoimmune pancreatitis (AIP) type 1 and type 2: an international consensus study on histopathologic diagnostic criteria. Pancreas 2011, 40:1172-1179.
33. Niederau C., Göpfert E. The effect of chelidonium- and turmeric root extract on upper abdominal pain due to functional disorders of the biliary system. Results from a placebo-controlled double-blind study. Medizinische Klinik (Munich) 1999, 94:425-430.
34. Matsubayashi H., Sawai H., Kimura H., et al. Characteristics of autoimmune pancreatitis based on serum IgG4 level. Digestive and Liver Disease 2011, 43:731-735.
35. Oseini A.M., Chaiteerakij R., Shire A.M., et al. Utility of serum immunoglobulin G4 in distinguishing immunoglobulin G4-associated cholangitis from cholangiocarcinoma. Hepatology 2011, 54:940-948.
36. Kalaitzakis E., Levy M., Kamisawa T., et al. Endoscopic retrograde cholangiography does not reliably distinguish IgG4-associated cholangitis from PSC or cholangiocarcinoma. Clinical Gastroenterology and Hepatology 2011, 9:800-803.
37. Raina A., Krasinskas A.M., Greer J.B., et al. Serum immunoglobulin G fraction 4 levels in pancreatic cancer: elevations not associated with autoimmune pancreatitis. Archives of Pathology and Laboratory Medicine 2008, 132:48-53.
38. Kimura Y., Harada K., Nakanuma Y. Pathologic significance of immunoglobulin G4-positive plasma cells in extrahepatic cholangiocarcinoma. Human Pathology 2012, 43:2149-2156.